Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
Blood Pressure Lowering Treatment Trialists' … - The Lancet, 2014 - Elsevier
Background We aimed to investigate whether the benefits of blood pressure-lowering drugs
are proportional to baseline cardiovascular risk, to establish whether absolute risk could be …
are proportional to baseline cardiovascular risk, to establish whether absolute risk could be …
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual …
Background The effects of pharmacological blood pressure lowering at normal or high-
normal blood pressure ranges in people with or without pre-existing cardiovascular disease …
normal blood pressure ranges in people with or without pre-existing cardiovascular disease …
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: a meta-analysis of individual participant data
KN Karmali, DM Lloyd-Jones, J van der Leeuw… - PLoS …, 2018 - journals.plos.org
Background Clinical practice guidelines have traditionally recommended blood pressure
treatment based primarily on blood pressure thresholds. In contrast, using predicted …
treatment based primarily on blood pressure thresholds. In contrast, using predicted …
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
D Ettehad, CA Emdin, A Kiran, SG Anderson… - The Lancet, 2016 - thelancet.com
Background The benefits of blood pressure lowering treatment for prevention of
cardiovascular disease are well established. However, the extent to which these effects …
cardiovascular disease are well established. However, the extent to which these effects …
Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study
E Herrett, S Gadd, R Jackson, K Bhaskaran… - The Lancet, 2019 - thelancet.com
Background Worldwide treatment recommendations for lowering blood pressure continue to
be guided predominantly by blood pressure thresholds, despite strong evidence that the …
be guided predominantly by blood pressure thresholds, despite strong evidence that the …
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta …
S Czernichow, A Zanchetti, F Turnbull… - Journal of …, 2011 - journals.lww.com
Background The benefits of reducing blood pressure are well established, but there remains
uncertainty about whether the magnitude of the effect varies with the initial blood pressure …
uncertainty about whether the magnitude of the effect varies with the initial blood pressure …
[HTML][HTML] Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an …
Background The effects of pharmacological blood-pressure-lowering on cardiovascular
outcomes in individuals aged 70 years and older, particularly when blood pressure is not …
outcomes in individuals aged 70 years and older, particularly when blood pressure is not …
Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk–overview and meta-analyses of …
C Thomopoulos, G Parati, A Zanchetti - Journal of hypertension, 2014 - journals.lww.com
Background: Randomized controlled trials (RCTs) of blood pressure (BP) lowering lend
themselves to be meta-analyzed to help providing evidence-based recommendations for …
themselves to be meta-analyzed to help providing evidence-based recommendations for …
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
F Turnbull, B Neal, C Algert, J Chalmers, M Woodward… - Lancet, 2003 - thelancet.com
Background The benefits of reducing blood pressure on the risks of major cardiovascular
disease are well established, but uncertainty remains about the comparative effects of …
disease are well established, but uncertainty remains about the comparative effects of …
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data …
M Nazarzadeh, Z Bidel, D Canoy… - The Lancet Diabetes & …, 2022 - thelancet.com
Background Controversy exists as to whether the threshold for blood pressure-lowering
treatment should differ between people with and without type 2 diabetes. We aimed to …
treatment should differ between people with and without type 2 diabetes. We aimed to …
相关搜索
- meta analysis blood pressure
- cardiovascular disease blood pressure
- meta analysis cardiovascular disease
- meta analysis participant level
- participant level blood pressure
- cardiovascular risk effects in patients
- effects in patients blood pressure
- treatment strategies blood pressure
- cardiovascular risk treatment strategies
- meta analysis treatment for prevention
- cardiovascular risk outcome incidence
- outcome incidence blood pressure
- pharmacotherapy for the prevention blood pressure
- cardiovascular risk blood pressure
- meta analysis cardiovascular risk
- meta analysis treatment strategies